Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

4.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
4.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations.

Frontiers in immunology·2026
Same author

An ancient retrotransposon provides species-specific tuning of IL-18 inflammatory signaling.

bioRxiv : the preprint server for biology·2026
Same author

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPF.

Science translational medicine·2026
Same author

Mitochondrial signatures of infant mesenchymal stem cells predict child adiposity: The Healthy Start Study.

Research square·2026
Same author

Genes, other than Muc5b, are associated with bleomycin-induced lung injury.

Communications biology·2026
Same author

Fibroblast memory Runx deep: epigenetic recall in pulmonary fibrosis.

American journal of respiratory cell and molecular biology·2026

Related Experiment Video

Updated: Mar 2, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.2K

Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic

Elizabeth F Redente1,2, Tengyao Song1, Nomin Javkhlan1

  • 1Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO, USA.

Nature Communications
|March 1, 2026
PubMed
Summary

Sustained BCL-2 expression in lung fibroblasts prevents apoptosis, driving persistent fibrosis in idiopathic pulmonary fibrosis (IPF). Inhibiting BCL-2 with ABT-199 resolves fibrosis and promotes lung regeneration.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.0K
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

12.2K

Related Experiment Videos

Last Updated: Mar 2, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.2K
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.0K
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

12.2K

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Fibrosis Research

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by chronic epithelial injury and fibroblast accumulation.
  • Unlike normal repair, IPF lungs exhibit apoptosis-resistant, pro-fibrotic fibroblasts that produce extracellular matrix.
  • This persistent fibroblast population contributes to progressive lung remodeling and disease severity.

Purpose of the Study:

  • To investigate the role of BCL-2 in fibroblast apoptosis and its contribution to the pathogenesis of IPF.
  • To explore the therapeutic potential of BCL-2 inhibition in resolving pulmonary fibrosis.

Main Methods:

  • Conditional BCL-2 expression in PDGFRα+ fibroblasts to prevent apoptosis in a mouse model.
  • Spatial transcriptomic analysis of human IPF lungs to identify senescent myofibroblasts.
  • Treatment of fibrotic mice with the selective BCL-2 inhibitor ABT-199.

Main Results:

  • Preventing fibroblast apoptosis via BCL-2 expression led to persistent senescent, pro-fibrotic fibroblasts and pathological lung remodeling.
  • Senescent, BCL-2-expressing myofibroblasts were identified in fibrotic regions of human IPF lungs.
  • ABT-199 treatment restored fibroblast apoptosis, reduced senescence, and promoted fibrosis resolution and lung regeneration in mice.

Conclusions:

  • Sustained BCL-2 expression in fibroblasts hinders homeostatic lung repair and drives persistent pulmonary fibrosis.
  • Targeting BCL-2 with inhibitors like ABT-199 represents a promising therapeutic strategy for reversing fibrosis in IPF.